0000950170-24-025878.txt : 20240305 0000950170-24-025878.hdr.sgml : 20240305 20240305160613 ACCESSION NUMBER: 0000950170-24-025878 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240302 FILED AS OF DATE: 20240305 DATE AS OF CHANGE: 20240305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: White Marvin L CENTRAL INDEX KEY: 0001493324 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37746 FILM NUMBER: 24720295 MAIL ADDRESS: STREET 1: 2273 RESEARCH BLVD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aptevo Therapeutics Inc. CENTRAL INDEX KEY: 0001671584 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 811567056 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 206-838-0500 MAIL ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 ownership.xml 4 X0508 4 2024-03-02 0001671584 Aptevo Therapeutics Inc. APVO 0001493324 White Marvin L 2401 4TH AVENUE 1050 SEATTLE WA 98121 true true false false President and CEO false Common Stock 2024-03-02 4 M false 12917 A 57846 D Common Stock 2024-03-03 4 M false 9584 A 67430 D Restricted Stock Unit 2024-03-02 4 M false 12917 0 D Common Stock 12917 25833 D Restricted Stock Unit 2024-03-03 4 M false 9584 0 D Common Stock 9584 9584 D Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. On March 3, 2023, the reporting person was granted 38,750 RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024. On June 7, 2022, the reporting person was granted 28,750 RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023. /s/ SoYoung Kwon, Attorney-in-Fact 2024-03-05